发明名称 New formulation
摘要 An oral dosage form comprising a core material coated with a semipermeable membrane wherein the core material comprises an active ingredient selected from the group of omeprazole, an alkaline salt thereof, <i>S</i>-omeprazole and an alkaline salt thereof, in admixture with one or more alkaline additives, one or more swelling agents, and optionally pharmaceutically acceptable excipients, and the dosage form is not enteric coated.
申请公布号 AU6034400(A) 申请公布日期 2001.01.09
申请号 AU20000060344 申请日期 2000.06.20
申请人 ASTRAZENECA AB 发明人 PER JOHAN LUNDBERG;BRITA SJOBLOM
分类号 A61K9/20;A61K9/00;A61K9/24;A61K9/36;A61K9/50;A61K31/4184;A61K31/4439;A61K47/02;A61K47/18;A61K47/32;A61K47/36;A61K47/38;A61P1/04 主分类号 A61K9/20
代理机构 代理人
主权项
地址